No abstract available
MeSH terms
-
Adrenergic Uptake Inhibitors / pharmacology
-
Adrenergic Uptake Inhibitors / therapeutic use*
-
Animals
-
Brain Stem / pathology
-
Brain Stem / physiopathology
-
Cells, Cultured / drug effects
-
Cells, Cultured / metabolism
-
Desipramine / pharmacology
-
Desipramine / therapeutic use*
-
Drug Evaluation, Preclinical
-
Female
-
Humans
-
Methyl-CpG-Binding Protein 2 / deficiency
-
Methyl-CpG-Binding Protein 2 / genetics
-
Methyl-CpG-Binding Protein 2 / physiology
-
Mice
-
Mice, Knockout
-
Nerve Tissue Proteins / deficiency
-
Neurons / enzymology
-
Neurons / pathology
-
Norepinephrine / deficiency
-
Norepinephrine / physiology
-
Respiration Disorders / drug therapy*
-
Respiration Disorders / etiology
-
Rett Syndrome / complications
-
Rett Syndrome / drug therapy*
-
Rett Syndrome / genetics
-
Rett Syndrome / physiopathology
-
Synaptic Vesicles / drug effects
-
Synaptic Vesicles / metabolism
-
Tyrosine 3-Monooxygenase / deficiency
Substances
-
Adrenergic Uptake Inhibitors
-
MECP2 protein, human
-
Mecp2 protein, mouse
-
Methyl-CpG-Binding Protein 2
-
Nerve Tissue Proteins
-
Tyrosine 3-Monooxygenase
-
Desipramine
-
Norepinephrine